Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure

scientific article

Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/EURJHF/HFS206
P698PubMed publication ID23329703

P2093author name stringHatsue Ishibashi-Ueda
Masafumi Kitakaze
Takuya Hasegawa
Masanori Asakura
Hiroyuki Takahama
Hideaki Kanzaki
Naoaki Yamada
Makoto Amaki
Akemi Yoshida
P2860cites workCardiovascular magnetic resonance in myocarditis: A JACC White PaperQ24654343
2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in AdultsQ28239484
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force CriteriaQ33764619
Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart AssociationQ34111674
Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel reportQ34364464
Current role of endomyocardial biopsy in the management of dilated cardiomyopathy and myocarditisQ34404739
From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart diseaseQ34515527
Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiographyQ35582468
An approach to endomyocardial biopsy interpretation.Q35769662
The pathology of hypertrophic cardiomyopathyQ35771667
Myocarditis: current trends in diagnosis and treatmentQ36395932
The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure SocieQ36981054
MRI of hypertrophic cardiomyopathy: part 2, Differential diagnosis, risk stratification, and posttreatment MRI appearancesQ37009534
Detection of myocardial damage in patients with sarcoidosisQ37424841
The role of cardiovascular magnetic resonance imaging in heart failureQ37606732
Myocarditis as a precipitating factor for heart failure: evaluation and 1-year follow-up using cardiovascular magnetic resonance and endomyocardial biopsyQ37850814
Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonanceQ38520098
EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phaseQ43291552
Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathyQ43954826
Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial DiseasesQ48689994
Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period.Q52915499
Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches.Q52938201
Myocardial biopsy findings and gadolinium enhanced cardiovascular magnetic resonance in dilated cardiomyopathy.Q53573264
Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patientsQ56999274
P433issue2
P921main subjectbiopsyQ179991
heart failureQ181754
P304page(s)166-175
P577publication date2013-02-01
P1433published inEuropean Journal of Heart FailureQ5017954
P1476titleDirect comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure
P478volume15

Reverse relations

cites work (P2860)
Q346773472016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contrib
Q38574702Advances in radionuclide imaging of cardiac sarcoidosis.
Q92740412Arrhythmogenic Left Ventricular Cardiomyopathy: A Clinical and CMR Study
Q38851511Biomarkers in sarcoidosis
Q60950653Cardiac Magnetic Resonance Imaging for Diagnosis of Cardiac Sarcoidosis: A Meta-Analysis
Q34617313Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment
Q38210202Cardiac magnetic resonance imaging for the investigation of cardiovascular disorders. Part 2: emerging applications
Q42668972Cardiac magnetic resonance imaging-indeterminate/negative cardiac sarcoidosis revealed by 18F-fluorodeoxyglucose-positron emission tomography: two case reports and a review of the literature.
Q33812953Cardiomyopathies: Evolution of pathogenesis concepts and potential for new therapies
Q37147335Complication rate of transfemoral endomyocardial biopsy with fluoroscopic and two-dimensional echocardiographic guidance: a 10-year experience of 228 consecutive procedures
Q48937315Detecting cardiac involvement with magnetic resonance in patients with active eosinophilic granulomatosis with polyangiitis
Q90324665Editorial: Diagnosis of cardiac sarcoidosis - What is the role of endomyocardial biopsy?
Q92715746Endomyocardial biopsy in patients with acute myocarditis, idiopathic dilated cardiomyopathy, and arrhythmogenic right ventricular dysplasia
Q39008785Fulminant isolated cardiac sarcoidosis with pericardial effusion and acute heart failure: Challenging aspects of diagnosis and treatment
Q33855587High sensitivity of late gadolinium enhancement for predicting microscopic myocardial scarring in biopsied specimens in hypertrophic cardiomyopathy
Q53646343Hospital volume and cardiac complications of endomyocardial biopsy: a retrospective cohort study of 9508 adult patients using a nationwide inpatient database in Japan.
Q87994873Non-contrast-enhanced T1 Mapping of Dilated Cardiomyopathy: Comparison between Native T1 Values and Late Gadolinium Enhancement
Q33165334Pathophysiology and clinical management of cardiac sarcoidosis.
Q35605428Prognostic impact of blood pressure response plus gadolinium enhancement in dilated cardiomyopathy.
Q39066632Severe Left Ventricular Endomyocardial Fibrosis Presenting as Biventricular Failure in a Young Adult: A Case Report
Q38177854Unveiling nonischemic cardiomyopathies with cardiac magnetic resonance

Search more.